Want to join the conversation?
Robert W. Baird analyst Richard Eastman questions $ROP as to what the core order number was in the quarter and what were its contributors. CEO Brian Jellison says that organically, orders were up 2%. The company says that organically, core orders in the Medical was 2%, RF was 9%, Industrial was 2% and Energy was negative 11%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?